1. Scrip
  2. >>Business

AviadoBio Targets Rare Form Of Dementia With Gene Therapy

With Targeted Thalamus Delivery

 
• By Ayisha Sharma

The UK biotech hopes to address a fast-progressing form of dementia that affects people earlier in life with a supplemental gene therapy delivered directly to the brain’s information centre.  

EPC AviadoBio
Frontotemporal Dementia Causes Cognitive, Speech And Behavioral Decline • Source: Shutterstock

AviadoBio Ltd. is preparing to take its lead gene therapy program to the clinic in a subset of dementia patients who could benefit from the greater precision of intra-thalamic delivery.

The firm was spun out of research conducted by neuroscientist Chris Shaw at King’s College, London. Shaw’s team focuses on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Emerging Company Profiles

More from Start-Ups & SMEs